The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1715
November 11, 2024
View Complete Issue         Table of Contents 2019 
Eroxon — An OTC Gel for Erectile Dysfunction
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Eroxon — An OTC Gel for Erectile Dysfunction
November 11, 2024 (Issue: 1715)
The FDA has authorized over-the-counter (OTC) sale of a nonmedicated alcohol-based gel (Eroxon – Futura) for treatment of erectile dysfunction (ED) in males ≥22 years old. Eroxon is the only FDA-approved OTC and topical treatment for erectile...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Eroxon — An OTC Gel for Erectile Dysfunction
Article code: 1715c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.